Literature DB >> 30259519

Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis.

Bobby V M Dasari1, Mihnea I Ionescu1, Timothy M Pawlik2, James Hodson3, Robert P Sutcliffe1, Keith J Roberts1, Paolo Muiesan1, John Isaac1, Ravi Marudanayagam1, Darius F Mirza1.   

Abstract

INTRODUCTION: Preoperative jaundice is considered a relative contraindication to radical gallbladder cancer (GBC) resection due to poor prognosis and high postoperative morbidity. Recent reports have indicated that aggressive surgery may improve long-term survival for patients with advanced GBC who present with obstructive jaundice. The current systematic review and meta-analysis aimed to compare postoperative outcomes among jaundiced and non-jaundiced patients with resectable GBC.
METHODS: An electronic search was performed using several Medical Subject Headings terms: cholecyst, gallbladder, tumor, cancer, carcinoma, adenocarcinoma, neoplasia, neoplasm, jaundice, and icterus. Overall survival after surgery was the primary outcome; resectability and postoperative morbidity were the secondary outcomes.
RESULTS: Overall survival was shorter among patients who presented with jaundice (Hazard ratio [HR]: 2.21, 95% confidence interval [CI], 1.64-2.97; P < 0.001). Patients with jaundice were less likely to have resectable disease (odds ratio: 0.27, 95% CI, 0.17-0.43; P < 0.001). The jaundice group had higher odds of postoperative morbidity, bile-leak, and posthepatectomy failure versus the non-jaundiced control group.
CONCLUSIONS: Radical surgery for GBC resection for patients presenting with obstructive jaundice was associated with reduced overall survival and increased postoperative morbidity. Jaundiced patients with advanced GBC should be considered for surgical resection but need careful evaluation and counseling before undertaking extensive surgical resection.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  gallbladder cancer (GBC); jaundice; outcomes

Mesh:

Year:  2018        PMID: 30259519     DOI: 10.1002/jso.25186

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  MAP kinase and mammalian target of rapamycin are main pathways of gallbladder carcinogenesis: results from bioinformatic analysis of next generation sequencing data from a hospital-based cohort (NCT05404347).

Authors:  Monika Rajput; Satyavjiay Chigurupati; Roli Purwar; Mridula Shukla; Manoj Pandey
Journal:  Mol Biol Rep       Date:  2022-08-26       Impact factor: 2.742

2.  Comparative Study of the Results of Operations in Patients with Tumor and Non-Tumor Obstructive Jaundice Who Received and Did Not Receive Antioxidant Therapy for the Correction of Endotoxemia, Glycolysis, and Oxidative Stress.

Authors:  Victor Stupin; Igor Abramov; Teymur Gahramanov; Alexey Kovalenko; Natalia Manturova; Petr Litvitskiy; Zalim Balkizov; Ekaterina Silina
Journal:  Antioxidants (Basel)       Date:  2022-06-20

3.  Surgical management of biliary malignancy.

Authors:  T Peter Kingham; Victoria G Aveson; Alice C Wei; Jason A Castellanos; Peter J Allen; Daniel P Nussbaum; Yinin Hu; Michael I D'Angelica
Journal:  Curr Probl Surg       Date:  2020-06-30       Impact factor: 1.909

4.  Upregulation of eukaryotic translation initiation factor 4E associates with a poor prognosis in gallbladder cancer and promotes cell proliferation in vitro and in vivo.

Authors:  Debao Fang; Jing Peng; Guobing Wang; Dachen Zhou; Xiaoping Geng
Journal:  Int J Mol Med       Date:  2019-08-19       Impact factor: 4.101

5.  Surgical treatment of gallbladder cancer: An eight-year experience in a single center.

Authors:  Yasuyuki Kamada; Tomohide Hori; Hidekazu Yamamoto; Hideki Harada; Michihiro Yamamoto; Masahiro Yamada; Takefumi Yazawa; Masaki Tani; Asahi Sato; Ryotaro Tani; Ryuhei Aoyama; Yudai Sasaki; Masazumi Zaima
Journal:  World J Hepatol       Date:  2020-09-27

6.  Oxidative Stress and Free Radical Processes in Tumor and Non-Tumor Obstructive Jaundice: Influence of Disease Duration, Severity and Surgical Treatment on Outcomes.

Authors:  Ekaterina Vladimirovna Silina; Victor Alexandrovich Stupin; Igor Sergeevich Abramov; Sergey Brankovich Bolevich; Gouri Deshpande; Raghu Ram Achar; Tatiana Georgievna Sinelnikova
Journal:  Pathophysiology       Date:  2022-01-31

7.  Impact of Primary Tumor Resection on Survival of Patients with Metastatic Gallbladder Carcinoma: A Population-Based, Propensity‑Matched Study.

Authors:  Jiang Xie; Zuofu Liao; Chao Sun; Zhonghao Chen
Journal:  Med Sci Monit       Date:  2022-04-02

Review 8.  Preoperative Assessment and Perioperative Management of Resectable Gallbladder Cancer in the Era of Precision Medicine and Novel Technologies: State of the Art and Future Perspectives.

Authors:  Gianluca Cassese; Ho-Seong Han; Yoo-Seok Yoon; Jun Suh Lee; Jai Young Cho; Hae-Won Lee; Boram Lee; Roberto Ivan Troisi
Journal:  Diagnostics (Basel)       Date:  2022-07-05

9.  Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma.

Authors:  Pinghua Yang; Fengliang Song; Xinwei Yang; Xingzhou Yan; Xinyu Huang; Zhengjun Qiu; Zhijian Wen; Chi Liang; Xianglei Xin; Zhengqin Lei; Kecheng Zhang; Jue Yang; Hu Liu; Hongcheng Wang; Shijun Xiang; Liang Li; Baohua Zhang; Hongyang Wang
Journal:  iScience       Date:  2022-07-21

10.  Extended Resections for Advanced Gallbladder Cancer: Results from a Nationwide Cohort Study.

Authors:  H Kuipers; E A J de Savornin Lohman; M van Dooren; A E Braat; F Daams; R van Dam; J I Erdmann; J Hagendoorn; F J H Hoogwater; B Groot Koerkamp; T M van Gulik; P R de Reuver; M T de Boer
Journal:  Ann Surg Oncol       Date:  2020-07-21       Impact factor: 5.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.